Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewPD 180970
Description: p210Bcr/Abl kinase inhibitor; also inhibits c-Src and KIT
Chemical Name: 6-(2,6-Dichlorophenyl)-2-[(4-fluoro-3-methylphenyl)amino]-8-methyl-pyrido[2,3-d]pyrimidin-7(8H)-one
Purity: ≥98% (HPLC)
Biological Activity for PD 180970
PD 180970 is an ATP-competitive inhibitor of p210bcr/abl tyrosine kinase; selectively induces apoptosis in chronic myeloid leukemia (CML) K562 cells. Inhibits in vivo tyrosine phosphorylation of Gab2, CrkL and p210bcr/abl (IC50 values are 80, 80 and 170 nM respectively). Potently inhibits p210bcr/abl autophosphorylation in vitro (IC50 = 5 nM). Also potently inhibits c-Src and KIT (IC50 values are 0.8 and 50 nM, respectively). Induces autophagy and reduces neuroinflammation in animal models of Parkinson's disease.
Licensing Information
Sold for research purposes under agreement from Pfizer Inc.
Technical Data for PD 180970
| M. Wt | 429.27 |
| Formula | C21H15Cl2FN4O |
| Storage | Store at +4°C |
| Purity | ≥98% (HPLC) |
| CAS Number | 287204-45-9 |
| PubChem ID | 5311104 |
| InChI Key | SLCFEJAMCRLYRG-UHFFFAOYSA-N |
| Smiles | CN(C(C(C4=C(Cl)C=CC=C4Cl)=C3)=O)C1=C3C=NC(NC2=CC(C)=C(F)C=C2)=N1 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Product Datasheets for PD 180970
References for PD 180970
References are publications that support the biological activity of the product.
Dorsey et al (2000) The pyrido[2,3-d]pyrimidine derivative PD180970 inhibits p210bcr-abl tyrosine kinase and induces apoptosis of K562 leukemic cells. Cancer Res. 60 3127 PMID: 10866298
Corbin et al (2004) Sensitivity of oncogenic KIT mutants to the kinase inhibitors MLN518 and PD180970. Blood 104 3754 PMID: 15304388
La Rosée et al (2002) Activity of the Bcr-Abl kinase inhibitor PD180970 against clinically relevant Bcr-Abl isoforms that cause resistance to ima. mesylate (Gleevec, STI571). Cancer Res. 62 7149 PMID: 12499247
Sn et al (2019) Small molecule modulator of aggrephagy regulates neuroinflammation to curb pathogenesis of neurodegeneration. EBioMedicine 50 260 PMID: 31727601
View Related Products by Target
View Related Products by Product Action
Keywords: PD 180970, PD 180970 supplier, PD180970, Pfizer, Bcr-Abl, tyrosine, kinase, inhibitors, inhibits, c-Src, KIT, Abl, Kinase, Src, Kinases, Other, RTKs, Autophagy, 4965, Tocris Bioscience
1 Citation for PD 180970
Citations are publications that use Tocris products. Selected citations for PD 180970 include:
Sn et al (2019) Small molecule modulator of aggrephagy regulates neuroinflammation to curb pathogenesis of neurodegeneration. EBioMedicine 50 260 PMID: 31727601
Reviews for PD 180970
There are currently no reviews for this product. Be the first to review PD 180970 and earn rewards!
Have you used PD 180970?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image